Starynets K, Paunkov A, Wagner A, Kratochwill K, Klotz C, Leitsch D
Int J Parasitol Drugs Drug Resist. 2025; 27:100585.
PMID: 39904006
PMC: 11847123.
DOI: 10.1016/j.ijpddr.2025.100585.
Muller J, Boubaker G, Muller N, Uldry A, Braga-Lagache S, Heller M
Int J Mol Sci. 2024; 25(13).
PMID: 39000012
PMC: 11241152.
DOI: 10.3390/ijms25136903.
Ranasinghe S, Armson A, Lymbery A, Zahedi A, Ash A
Pathog Glob Health. 2023; 117(6):535-553.
PMID: 36805662
PMC: 10392325.
DOI: 10.1080/20477724.2023.2179454.
Emery-Corbin S, Su Q, Tichkule S, Baker L, Lacey E, Jex A
Int J Parasitol Drugs Drug Resist. 2021; 16:162-173.
PMID: 34237690
PMC: 8267433.
DOI: 10.1016/j.ijpddr.2021.05.003.
Lopes-Oliveira L, Fantinatti M, Da-Cruz A
Mem Inst Oswaldo Cruz. 2020; 115:e200303.
PMID: 33146255
PMC: 7607557.
DOI: 10.1590/0074-02760200303.
An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery.
Tiash S, Saunders J, Hart C, Ryan J, Riches A, Skinner-Adams T
Int J Parasitol Drugs Drug Resist. 2020; 12:60-67.
PMID: 32234669
PMC: 7113605.
DOI: 10.1016/j.ijpddr.2020.03.002.
Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics.
Muller J, Braga S, Heller M, Muller N
Int J Parasitol Drugs Drug Resist. 2019; 9:112-119.
PMID: 30889439
PMC: 6423486.
DOI: 10.1016/j.ijpddr.2019.03.002.
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity.
Jarrad A, Ang C, Debnath A, Hahn H, Woods K, Tan L
J Med Chem. 2018; 61(24):11349-11371.
PMID: 30468386
PMC: 6311682.
DOI: 10.1021/acs.jmedchem.8b01578.
Differential protein expression and post-translational modifications in metronidazole-resistant Giardia duodenalis.
Emery S, Baker L, Ansell B, Mirzaei M, Haynes P, McConville M
Gigascience. 2018; 7(4).
PMID: 29688452
PMC: 5913674.
DOI: 10.1093/gigascience/giy024.
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.
Kim W, Korthals K, Li S, Le C, Kalisiak J, Sharpless K
Antimicrob Agents Chemother. 2017; 61(6).
PMID: 28396548
PMC: 5444119.
DOI: 10.1128/AAC.02397-16.
Transcriptomics Indicates Active and Passive Metronidazole Resistance Mechanisms in Three Seminal Lines.
Ansell B, Baker L, Emery S, McConville M, Svard S, Gasser R
Front Microbiol. 2017; 8:398.
PMID: 28367140
PMC: 5355454.
DOI: 10.3389/fmicb.2017.00398.
A novel in vitro image-based assay identifies new drug leads for giardiasis.
Hart C, Munro T, Andrews K, Ryan J, Riches A, Skinner-Adams T
Int J Parasitol Drugs Drug Resist. 2017; 7(1):83-89.
PMID: 28171818
PMC: 5295624.
DOI: 10.1016/j.ijpddr.2017.01.005.
Identification and Validation of Small-Gatekeeper Kinases as Drug Targets in Giardia lamblia.
Hennessey K, Smith T, Xu J, Alas G, Ojo K, Merritt E
PLoS Negl Trop Dis. 2016; 10(11):e0005107.
PMID: 27806042
PMC: 5091913.
DOI: 10.1371/journal.pntd.0005107.
Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
Jarrad A, Debnath A, Miyamoto Y, Hansford K, Pelingon R, Butler M
Eur J Med Chem. 2016; 120:353-62.
PMID: 27236016
PMC: 4920673.
DOI: 10.1016/j.ejmech.2016.04.064.
Metronidazole-triazole conjugates: activity against Clostridium difficile and parasites.
Jarrad A, Karoli T, Debnath A, Tay C, Huang J, Kaeslin G
Eur J Med Chem. 2015; 101:96-102.
PMID: 26117821
PMC: 4550478.
DOI: 10.1016/j.ejmech.2015.06.019.
Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance.
Penuliar G, Nakada-Tsukui K, Nozaki T
Front Microbiol. 2015; 6:354.
PMID: 25999919
PMC: 4419850.
DOI: 10.3389/fmicb.2015.00354.
Discovery of novel antigiardiasis drug candidates.
Kulakova L, Galkin A, Chen C, Southall N, Marugan J, Zheng W
Antimicrob Agents Chemother. 2014; 58(12):7303-11.
PMID: 25267663
PMC: 4249522.
DOI: 10.1128/AAC.03834-14.
Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram.
Galkin A, Kulakova L, Lim K, Chen C, Zheng W, Turko I
J Biol Chem. 2014; 289(15):10502-10509.
PMID: 24558036
PMC: 4036171.
DOI: 10.1074/jbc.M114.553123.
Current treatment options for Dientamoeba fragilis infections.
Nagata N, Marriott D, Harkness J, Ellis J, Stark D
Int J Parasitol Drugs Drug Resist. 2014; 2:204-15.
PMID: 24533282
PMC: 3862407.
DOI: 10.1016/j.ijpddr.2012.08.002.
Barcoding of Giardia duodenalis isolates and derived lines from an established cryobank by a mutation scanning-based approach.
Nolan M, Jex A, Upcroft J, Upcroft P, Gasser R
Electrophoresis. 2013; 32(16):2075-90.
PMID: 23479788
PMC: 3810208.
DOI: 10.1002/elps.201100283.
